Plain-English translation of NCT07404397 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing two different approaches to help people with chronic pelvic pain caused by high-tone pelvic floor dysfunction โ a condition where pelvic muscles are too tight. One group will use , a muscle relaxant medication, while the other group will use a vibrating pelvic floor massage wand. Both groups will also receive physical therapy designed to treat this condition. The researchers want to see which approach works better at relieving pain and improving muscle function.
Chronic pelvic pain from tight pelvic floor muscles is a common and difficult problem that significantly affects quality of life. This trial exists to find the best way to prepare patients for physical therapy and manage their pain โ by comparing a medication approach with a device-based approach.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will be randomly assigned to either the medication group or the massage device group. For the first 9 weeks (Phase 1), you'll use your assigned treatment at home daily while filling out surveys about your pain. Then for the next 9 weeks (Phase 2), you'll continue your treatment while attending 12 sessions of specialized pelvic floor physical therapy with a trained therapist. Throughout the study, you'll have several clinic visits where a specialist will examine your pelvic floor muscles, perform some sensory tests, and draw blood samples. The entire study lasts about 18 weeks total.
AI-generated summary from trial data ยท Aug 24, 2026 ยท Not medical advice
United States